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Secondary metabolites from Bacillus 
amyloliquefaciens isolated from soil can kill 
Burkholderia pseudomallei
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Abstract 
Bacillus species are Gram-positive bacteria found in abundance in nature and their secondary metabolites were found 
to possess various potential activities, notably antimicrobial. In this study, Bacillus amyloliquefaciens N2-4 and N3-8 
were isolated from soil and their metabolites could kill Burkholderia pseudomallei, a Gram-negative pathogenic bac-
terium also found in soil in its endemic areas. Moreover, the metabolites were able to kill drug resistant isolates of B. 
pseudomallei and also inhibit other pathogenic bacteria such as Staphylococcus aureus, Escherichia coli and Acinetobac-
ter baumannii but not the non-pathogenic Burkholderia thailandensis, which is closely related to B. pseudomallei. Since 
the antimicrobial activity of N3-8 was not partially decreased or abolished when treated with proteolytic enzymes or 
autoclaved, but N2-4 was, these two strains should have produced different compounds. The N3-8 metabolites with 
antimicrobial activity consisted of both protein and non-protein compounds. The inhibition spectrum of the precipi-
tated proteins compared to the culture supernatant indicated a possible synergistic effect of the non-protein and 
peptide compounds of N3-8 isolates against other pathogens. When either N2-4 or N3-8 isolates was co-cultured with 
B. pseudomallei the numbers of the bacteria decreased by 5 log10 within 72 h. Further purification and characterization 
of the metabolites is required for future use of the bacteria or their metabolites as biological controls of B. pseudomal-
lei in the environment or for development as new drugs for problematic pathogenic bacteria.
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Introduction
Bacillus spp. are Gram-positive bacteria found diversely 
in nature especially in soil. In unsuitable conditions such 
as high temperature, radiation and harsh chemical rea-
gents, they can form endospores for survival (Errington 
2003). Besides spore forming, Bacillus spp. are also able 
to produce secondary metabolite products (Sansine-
nea and Ortiz 2011), which is an additional function to 
compete against other organisms. Bioactive compounds 
from Bacillus subtilis, bacteriocin-like substances, were 
reported to inhibit several clinical bacteria such as Lis-
teria monocytogenes, Staphylococcus aureus, Bacil-
lus cereus, Salmonella typhi (Xie et  al. 2009) and also a 
substance from Bacillus licheniformis could inhibit food 
spoilage bacteria (Guo et al. 2012). Moreover, the culture 
supernatant from Bacillus spp. isolated from soil named 
KW and SA was reported to contain N-acyl homoserine 
lactone that significantly decreased biofilm formation of 
Burkholderia pseudomallei (Ramli et  al. 2012). In addi-
tion, the Bacillus strain TKS1-1 in endospore form, was 
used to reduce the incidence of citrus bacterial canker 
(Huang et al. 2012). Some Bacillus spp. can produce sev-
eral types of active compounds such as B. amyloliquefa-
ciens FZB42 that has 8.5% of the genome dedicated for 
the synthesis of secondary metabolites (Chen et al. 2007). 
It can produce lipopeptides; surfactin, fengycin, bacillo-
mycin D, polyketide (difficidin) and dipeptide bacilysin 
that can suppress growth of Erwinia amylovora (Chen 
et al. 2009).
Open Access
*Correspondence:  rasana@kku.ac.th 
1 Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 
123 Mitraparb Rd, Muang District, Khon Kaen Province 40002, Thailand
Full list of author information is available at the end of the article
Page 2 of 11Boottanun et al. AMB Expr  (2017) 7:16 
Melioidosis is one of infectious diseases that pose a 
significant public health problem in Southeast Asia and 
North Australia. The causative agent is B. pseudomal-
lei, a Gram-negative bacteria which can be found in soil 
and water in endemic areas (Cheng and Currie 2005). 
Melioidosis is the third most cause of death among the 
infectious diseases in northeast Thailand and is respon-
sible for 20% of community acquired septicemias with 
a 40% mortality rate (Wiersinga et  al. 2012). The bacte-
rium is intrinsically resistant to several antibiotics and 
acquired resistant to ceftazidime the drug of choice after 
lost a penicillin-binding protein 3 gene (Chantratita 
et al. 2011). Burkholderia pseudomallei was found to be 
unevenly distributed in soil and that the physicochemi-
cal properties of soil may partially influence the presence 
and absence of the bacterium (Ngamsang et  al. 2015; 
Palasatien et  al. 2008). Some microbes in soil may also 
inhibit or compete by producing some active compounds 
against the bacteria.
In this study, it was therefore of interest to screen for 
Bacillus spp. in soils that were negative for B. pseudomal-
lei and characterize the metabolites that could inhibit or 
kill B. pseudomallei. The Bacillus spp. themselves or their 
antimicrobial metabolites might then be used as bio-con-




Bacterial strains used to test for the inhibition spectrum 
of B. amyloliquefaciens metabolites are listed in Addi-
tional file 1: Table S1. They were obtained from the Meli-
oidosis Research Center, Faculty of Medicine Khon Kaen 
University, Thailand and also kindly provided by Asso-
ciate Professor Julian G. Hurdle’s laboratory, Center for 
Infectious and Inflammatory diseases, Institute of Bio-
sciences and Technology, Texas A&M University, USA. 
Our bacterial strains were deposited in culture collec-
tion belonging to World Data Centre for Microorganism 
(WDCM) as MRCKKU (registration number 1130).
Isolation of Bacillus spp. from soil
Twenty-five soil samples that were confirmed as nega-
tive for B. pseudomallei by culture and semi-nested PCR 
(Ngamsang et al. 2015) were used for isolation of Bacillus 
spp.
The protocol for isolation of Bacillus spp. from soil was 
according to Travers et  al. (1987) described with some 
modifications. One gram of each soil sample was mixed 
with 10 ml sterile distilled water and boiled at 100 °C for 
5  min to kill other vegetative cells. Thereafter, superna-
tants were diluted by 10-fold serial dilution and 100 µl of 
the 10−2, 10−3, 10−4 dilutions were spread onto nutrient 
agar (NA) plates and incubated at 37 °C for 18–24 h. Bac-
terial isolates with colony morphology of large, dry, white 
color with wavy, lobed margins were selected to sub-
culture and confirmed by the Gram’s stain. These isolates 
were tested for their ability to kill B. pseudomallei and 
other pathogens.
Agar well diffusion method for screening of antimicrobial 
activity
Antimicrobial activity against B. pseudomallei or other 
pathogens of culture supernatants and precipitated pro-
tein from culture supernatants of Bacillus spp. were 
investigated by the agar well diffusion method (Umer 
et al. 2013). In brief, overnight 1% cultures in Luria Ber-
tani (LB) medium of B. pseudomallei and other indica-
tor bacteria were inoculated into fresh LB medium and 
incubated at 37  °C, 200  rpm for 4  h until the log phase 
and were then used at approximately 105–106 CFU/ml 
to swab on Müller-Hinton agar (MHA) plates. The plates 
were punched to obtain 6.6  mm wells by sterile pipette 
tips and then 100 µl of sterile supernatant or precipitated 
proteins were added into each well. Ceftazidime (Sigma-
Aldrich, St. Loius, MO, USA) at 50 µg/ml concentration 
was used as the positive control and minimal medium 
was used as the negative control. The plates were left 
at room temperature for 1  h before being incubated at 
37  °C, for 18–24  h. Inhibition activity was evaluated by 
measuring the diameter of inhibition zone against B. 
pseudomallei.
Species identification
N2-4 and N3-8 with inhibitory activity against B. pseu-
domallei were selected for gDNA extraction with an RBC 
kit (RBC ribosicen, Taiwan) and were then used for PCR 
amplification using universal primers against the con-
served region in 16s rDNA gene (Rd1; 5′AAGGAGGT 
GATCCAGCC3′, Fd1; 5′AGTTTGATCCTGGCTCAG3′) 
(Ghribi et  al. 2012). The master mix of PCR contained 
2.5 µl of 10X PCR buffer, 0.16 mM dNTP, 2.0 mM MgCl2, 
0.1  µM of each primer, 0.04  unit/ml of Taq DNA poly-
merase, 50  ng of DNA template and DNase-free water 
to a final volume of 25 µl. The PCR products were ana-
lyzed with 1.2% agarose gel electrophoresis and stained 
with SYRB Gold. The expected PCR products of 1500 bps 
were sequenced (First Base laboratories Sdn Bhd, Malay-
sia) and the BLASTn program was used (Altschul et  al. 
1997; National Center for Biotechnology Information 
2015) to identify their species.
Production kinetics of antimicrobial metabolites
N2-4 and N3-8 were cultured in duplicate in 200  ml 
of minimal medium composed of 5.0  g l-glutamic 
acid, 0.5  g KH2PO4, 0.5  g K2HPO4, 0.2  g MgSO4·7H2O, 
Page 3 of 11Boottanun et al. AMB Expr  (2017) 7:16 
0.01  g MnSO4·H2O, NaCl 0.01  g, FeSO4·7H2O 0.01  g, 
CuSO4·7H2O 0.01 g and CaCl2·2H2O 0.015 g/L. This was 
supplemented with 1% w/v sterile glucose as described by 
Jamil et al. (2007) at 37 °C with 200 rpm shaking for 102 h. 
Every 6  h, 1  ml of the culture was sampled to obtain the 
culture supernatant for antimicrobial activity to test against 
B. pseudomallei using the agar well diffusion method.
Partial characterization of antimicrobial metabolites 
from N2‑4 and N3‑8
Proteolytic enzymes susceptibility test
The culture supernatants from N2-4 and N3-8 were 
treated with 200 µg/ml of proteinase K (Amresco, Solon, 
OH, USA) and 1  mg/ml of pepsin, trypsin and papain 
(Sigma-Aldrich, St. Loius, MO, USA) at final concentra-
tions and incubated at 37 °C for 3 h. For inactivation, the 
proteinase K was processed at 75 °C for 10 min or 100 °C 
for 5 min for the other three enzymes to determine the 
antimicrobial activity against B. pseudomallei by the agar 
wells diffusion method.
Thermo stability test
The culture supernatants from N2-4 and N3-8 were incu-
bated at 25, 37, 40, 50, 60, 70, 80, 90, 100, and 121  °C 
for 15  min and then tested for the antimicrobial activ-
ity against B. pseudomallei by the agar well diffusion 
method.
Antimicrobial spectrum
For a quick screening of the antimicrobial activity, the 
cross steak method was used as described by Hemashen-
pagam with some modifications (Hemashenpagam 2011). 
N2-4 or N3-8 isolates were streaked as a line at the center 
of the NA plate and incubated for 72  h. After that, the 
overnight culture of indicator bacteria (Additional file 1: 
Table S1) was streaked across the single streak of N2-4 
and N3-8 isolates and incubated at 37  °C for 24  h. The 
qualitative grading of inhibition assigned ++++ for 
the highest, +++ for moderate, ++ for a few, + for low 
activity and − for no inhibition.
Production of proteins from N2‑4 and N3‑8
The production medium of secondary metabolites is a 
minimal medium supplemented with 1% w/v glucose 
sterile with a filtered 0.2  µm syringe (Jamil et  al. 2007). 
One percent of both B. amyloliquefaciens N2-4 and N3-8 
were inoculated into minimal media and kept at 37  °C, 
200  rpm for 72  h. The cultured supernatants were har-
vested by centrifugation at 16,000×g for 15 min, (Avanti® 
J-E, Beckman Coulter, CA, USA) and then filtered 
through a 0.2  µm membrane. These crude metabolites 
were used for protein purification or kept at −20 °C until 
used for the inhibition assay.
Partial purification of proteins
Culture supernatants from N2-4 and N3-8 were pre-
cipitated using 20, 40, 60 and 80% saturated ammonium 
sulfate ((NH4)2SO4) as described by Sharma with some 
modification (Sharma et  al. 2009). The precipitated 
proteins were harvested by centrifugation at 13,000×g 
(Avanti® J-E, Beckman Coulter, CA, USA) at 4  °C for 
20  min. The protein pellets were then re-suspended in 
TE buffer pH 8.0 (10 mM Tris–HCl, 1 mM EDTA) and 
dialyzed with similar buffers using a dialysis bag with a 
3.5  kDa cut off (Thermo scientific, Rockford, IL, USA) 
at 4 °C overnight. The activity of these precipitated pro-
teins was confirmed against B. pseudomallei and other 
pathogenic bacteria by the agar well diffusion method. 
The concentrations of the precipitated proteins were 
measured by the Bradford technique (Biorad, CA, USA) 
according to the manufacturers’ protocol.
The precipitated proteins were prepared to have a con-
centration of 3.0 mg/ml and were tested for antimicrobial 
activity against 14 pathogenic bacteria by the agar well 
diffusion method as listed in the Additional file 1: Table 
S1.
Time‑kill assay of the precipitated proteins
The time-kill assay, as described by Sopirala et al. (2010), 
with some modifications, was used to determine the 
time that B. pseudomallei was killed after N2-4 and N3-8 
precipitated proteins were added into the B. pseudomal-
lei cultures. Briefly, 3.0  mg/ml of precipitated proteins 
were twofold serial diluted with MHB in 24-well plates 
and then added 105–106 CFU/ml of B. pseudomallei and 
incubated at 37 °C. After incubation for 3, 6, 12 and 24 h, 
100  µl from each dilution was 10-fold serially diluted 
with PBS pH 7.2 and 10 µl of each dilution were used to 
drop on selective Ashdown’s agar (Naghili et al. 2013) for 
B. pseudomallei colony counts.
Minimum inhibitory concentration (MIC) and Minimum 
bactericidal concentration (MBC) of antimicrobial 
compounds
The precipitated proteins from N2-4 and N3-8 isolates 
were filtered through 0.2  µm membranes and the con-
centrations adjusted to 3.0 mg/ml and used to determine 
the MIC and MBC by micro-broth dilution (Hoelzer 
et al. 2011). In brief, the antimicrobial compounds were 
diluted in 96-well plates by twofold serial dilutions using 
MHB. Then B. pseudomallei of approximately 105–106 
CFU/ml was added into each well, mixed gently and 
then incubated at 37 °C for 18–24 h. The last concentra-
tion that provided clear solution when compared to the 
growth control was recorded as the MIC. The MBC was 
evaluated by pipette each dilution from the clear wells, 
diluting with PBS pH 7.2 and then 10 µl of each dilution 
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was dropped onto Ashdown’s agar for colony counts. The 
interpretation was that the MBC must have decreased ≥3 
log10  CFU/ml or 99.9% of the bacterial cell count when 
compared to growth control.
Identification of proteins with antimicrobial activity
The precipitated proteins were separated by native-PAGE 
in the tris–glycine system and the separated bands were 
used to test for the inhibitory activity as described by 
Barbaza-Corana (2007) with some modifications. Pre-
cipitated proteins were separated in duplicate; one strip 
was washed with sterile deionized water and placed on 
the MHA plate that was spread with 105–106 CFU/ml 
B. pseudomallei, the strip without proteins loading was 
used as negative control. The inhibition zone against B. 
pseudomallei that was caused by proteins was observed 
after incubation at 37  °C for 18–24  h. Another strip of 
this gel was stained with silver stain (Schägger 2006) to 
determine the molecular weight of the protein band that 
showed inhibition activity.
Bio‑control of B. pseudomallei using B. amyloliquefaciens
B. pseudomallei at 6  ×  106  CFU/ml were co-cultured 
with 6 × 104 CFU/ml of N2-4 or N3-8 isolates in 100 ml 
of LB medium in 250 ml Erlenmeyer flasks and incubated 
at 37 °C with 200 rpm shaking. The experiment was done 
in triplicate. Burkholderia pseudomallei cultured in the 
same condition was used as a control. The viability of B. 
pseudomallei was measured after co-culture for 24, 48, 
72 and 96 h using the plate count method on Ashdown’s 
agar.
Results
Bacterial isolation and species identification
Sixty-six isolates of Gram-positive bacilli, with morphol-
ogy of being large, dry, white colored, with wavy, lobed 
margins were obtained. After the antimicrobial activity 
against B. pseudomallei was observed by the agar well 
diffusion method, the two isolates named N2-4 and N3-8 
showed clear zones of inhibition (Fig. 1). PCR amplifica-
tion against the conserved regions in 16s rDNA genes of 
N2-4 and N3-8 gave the expected 1500 bps products. The 
nucleotide sequences shown by BLASTn indicated 99% 
similarity to B. amyloliquefaciens. The accession numbers 
of 16 s rDNA that were identical to 16 s rDNA of N2-4 
and N3-8 are KC887505.1 and HG32825.1.
Production time of antimicrobial metabolites
The metabolites from B. amyloliquefaciens N3-8 showed 
more broadened antimicrobial activity against B. pseu-
domallei and was therefore selected to grow in minimum 
medium in duplicate to observe the production of anti-
microbial metabolites in time by the agar well diffusion 
method. After being cultured for 12 and 14 h, the culture 
supernatants from N3-8 and N2-4 started to show inhi-
bition against B. pseudomallei. The highest antimicrobial 
activity was observed at 60–72 h with the inhibition zone 
of 20 and 17 mm (Fig. 2).
Partial characterization of antimicrobial metabolites 
from B. amyloliquefaciens
Proteolytic digestion and temperature stability
When the culture supernatants from N3-8 were heated 
from 25  °C to 121  °C for 15  min, the activity against B. 
pseudomallei decreased at 40–100  °C and was almost 
halved when autoclaved at 121  °C while metabolites 
from N2-4 showed decreased in activity after heating 
at 80–100  °C and were abolished by being autoclaved 
(Additional file 1: Table S2). The activities of the culture 
supernatants from N3-8 were partially decreased when 
treated with all proteolytic enzymes while those of N2-4 
were abolished by proteinase K and trypsin and partially 
decreased by papain and pepsin digestion (Additional 
file 1: Table S3).
Antimicrobial spectrum of N2‑4 and N3‑8
The culture supernatants from N3-8 inhibited 100% of 
B. pseudomallei clinically sourced strains, 83% of envi-
ronmentally sourced strains, 100% ceftazidime resistant 
and 100% in mutant isolates while N2-4 inhibited these 
Fig. 1 The antimicrobial activity of culture supernatants from B. 
amyloliquefaciens N2-4 and N3-8 isolates against B. pseudomallei. 
The inhibitory activity of culture supernatants from B. amylolique-
faciens N2-4 and N3-8 isolates against B. pseudomallei by the agar 
well diffusion method as seen by clear zones, MM minimal medium 
(negative control), CAZ ceftazidime 50 µg/mL, the drug of choice for 
B. pseudomallei (positive control)
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same strains at 87, 67, 80 and 60% (Table 1). They did not 
inhibit all 12 isolates of B. thailandensis, a non-patho-
genic bacterium that is closely related to B. pseudomallei. 
Using the cross streak method, N2-4 and N3-8 isolates 
had clear inhibition activity against Gram-positive bac-
teria such as S. aureus, Clostridium difficile and Entero-
coccus faecium and other Gram-negative bacteria such as 
B. pseudomallei, Acinetobacter baumannii, Pseudomonas 
aeruginosa and E. coli (Additional file 1: Table S4).
Partial purification and antimicrobial activity 
of precipitated proteins
Sixty percent of saturated ammonium sulfate gave the 
precipitated proteins from the culture supernatants of 
N2-4 and N3-8 with the highest inhibition activity against 
B. pseudomallei. When these precipitated proteins from 
N2-4 and N3-8 were tested against Gram-positive and 
Gram-negative bacteria, they effectively inhibited S. pyo-
genes, S. pneumonia and Moraxella catarrhalis as shown 
with very large clear zones of inhibition (Table 2). Precip-
itated proteins from N3-8, in general, showed larger clear 
zones than N2-4.
The MICs of precipitated proteins from N2-4 and N3-8 
were 0.19 and 0.02  mg/ml. For MBCs, the concentra-
tions of precipitated proteins from N2-4 and N3-8 that 
decreased B. pseudomallei colony counts by 99% were 
0.75 and 0.04 mg/ml.
Time‑kill assay of precipitated proteins
The results from MBC assay confirmed that precipitated 
proteins from N2-4 and N3-8 could kill B. pseudomallei. 
The N2-4 precipitated proteins at concentrations of 3.0, 
1.5 and 0.75 mg/ml could kill B. pseudomallei within 3, 6 
and 12 h (Fig. 3a). N3-8 proteins of 3.0 mg/ml could kill 
B. pseudomallei within 3 h and 0.09-1.5 mg/ml killed B. 
pseudomallei in 6 h and 0.04 mg/ml killed B. pseudomal-
lei after being treated for 12  h (Fig.  3b). Therefore, the 
killing activity of these active compounds was in a dose 
dependent manner.
Identification of proteins with antimicrobial activity
Following the results of the in-gel overlay assay, the major 
active compounds that shown inhibitory activity against 
B. pseudomallei appeared at the lower end of the gel at 
the approximate molecular weight of less than 11 kDa as 
shown by silver stained gel (Fig. 4a, b). The active com-
pounds could be small molecules as separate bands on 
the silver stain gel.
Bio‑control of B. pseudomallei in liquid medium
N2-4 and N3-8 were co-cultured with 6.0  ×  106  CFU/
ml of B. pseudomallei at a ratio of 1:100 in LB broth. The 
growth rate of B. pseudomallei appeared to be decreased 
by 5 log10 at 72 h after incubation when compared to the 
control growth (Fig. 5).
Fig. 2 The production of secondary metabolites from B. amyloliquefaciens N2-4 and N3-8 isolates. The production of secondary metabolites dis-
played as sizes of the inhibition zones in nm against B. pseudomallei as evaluated by the agar well diffusion method from N2-4 (green bars) and N3-8 
(purple bars) were plotted on the left Y axis and growth curve as measured at OD540 nm of N2-4 (blue line) and N3-8 (red line) were plotted on the 
right Y axis, while X axis represent the time in hours
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Discussion
Bacillus amyloliquefaciens was reported to be a plant 
promoting bacterium that was associated with rhizos-
pheres as they consume nutrients from the plant. More-
over, this group of bacteria could produce secondary 
metabolites to suppress plant pathogens and also pro-
duce compounds to promote plant growth (Idris et  al. 
2007). The completed genome of 3918 Kb of the FZB42 
strain showed a total of 8.5% of genetic material to be 
associated with the synthesis function of the non-riboso-
mal secondary metabolites (Chen et  al. 2007) and 3693 
sequences encoded for proteins. B. amyloliquefaciens 
FZB42 produces several non-ribosomal peptide products 
such as lipopeptides; surfactin, fengycin, and bacillomy-
cin D (Koumoutsi et al. 2004) that can inhibit Fusarium 
oxysporum and polyketides; bacillaene, difficidin and 
macrolactin that also inhibited F. oxysporum (Chen et al. 
2006; Schneider et  al. 2007). Moreover, the peptides 
plantazolicin A, B and cyclic peptides amylocyclicin pro-
duced from this bacterium were also reported to inhibit 
B. subtilis and other closely related bacteria (Kalyon et al. 
2011; Scholz et  al. 2014). Bacilysin a dipeptide product 
from B. amyloliquefaciens FZB42 was able to suppress 
growth of E. amylovora which is the causative agent of 
fire blight disease (Chen et al. 2009). In this current study, 
B. amyloliquefaciens N2-4 and N3-8 that were isolated 
from soil, negative for B. pseudomallei, could inhibit B. 
pseudomallei and a wide range of human pathogens.
The metabolites with antimicrobial activity secreted 
from B. amyloliquefaciens N2-4 and N3-8 isolates were 
produced at the early to mid-stationary phase (12–72 h) 
when cell density become increased and the activ-
ity decreased after 78  h of cultivation. This character-
istic fits well to the secondary metabolites that can be 
induced by multifactor such as stress, starvation or envi-
ronmental factors and also cell-to-cell communication 
or quorum sensing which use small peptides as inducer 
(Kleerebezem and Quadri 2001). Antimicrobial activ-
ity of compounds from Bacillus spp. from the Amazon 
river basin were also capable of producing compounds 
with antimicrobial activity at the exponential phase and 
reached their peak at the stationary phase (Motta et  al. 
2007). The antimicrobial activity of culture superna-
tant from N2-4 were decreased by heat, abolished when 
autoclaved and can be completely destroyed by proteo-
lytic enzymes suggesting that the main active compounds 
against B. pseudomallei are proteins. For N3-8, the heat, 
autoclaving and proteolytic enzymes digestion could only 
partially decrease the activity. Therefore, the active com-
pounds should compose of peptides that can be digested 
by proteolytic enzyme and other compounds that resist 
Table 1 The antimicrobial activity of  culture supernatant 
from B. amyloliquefaciens N2-4 and N3-8 isolates against B. 
pseudomallei and B. thailandensis
No. in brackets indicated number of test isolates
− Not inhibited, + inhibited
Bacterial indicators B. amyloliquefaciens 
N2‑4 supernatants
B. amyloliquefaciens  
N 3‑8 supernatants







B. pseudomallei CAZ 
resistance strains (5)
4 5
B. pseudomallei mutant 
strains (5)
3 5
 M6 biofilm mutant − +
 M10 biofilm mutant + +
 SRM117 LPS O-side 
chain mutant
− +
 MM35 flagellin 
mutant
+ +
 SR1015 capsule 
mutant
+ +
B. thailandensis (12) 0 0
Table 2 The antimicrobial activity of precipitated proteins 
from  B. amyloliquefaciens N2-4 and  N3-8 against  patho-
genic bacteria
















 B. pseudomallei p37 21 24
 Moraxella catarrhalis >30 >30
 Citrobacter freundii 14 18.5
 Salmonella group D 14.5 23
 Proteus vulgaris 14.5 23
 Escherichia coli 11 19.5
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to proteolytic enzyme and high temperature conditions. 
As mentioned, Bacillus spp. were reported to produce 
both peptides and non-ribosomal peptide antibiotics that 
can inhibit peptidoglycan synthesis or cause pore for-
mation using some specific molecules such as lipid II or 
the mannose phosphate transferase system (man-PTS) 
as a docking molecule (Cotter et al. 2013). Lipopeptides 
are metabolites that can function as a pore formation 
or emulsification on the target organism. Several pep-
tides and bacteriocin-like substances from Bacillus spp. 
were reported to stable at a wide range of temperatures 
(30–80 °C) (Cao et al. 2011; Hammami et al. 2009; Sutyak 
et al. 2008). CLI proteins, for example, were stable up to 
60  °C and lost activity after being autoclaved at 121  °C 
(Meng et  al. 2012) and a peptide subtilosin was stable 
after heat at 100  °C (Sutyak et al. 2008). The antimicro-
bial substances from B. amyloliquefaciens N2-4 and 
N3-8 were stable up to 25–100 °C and some activity was 
decreased when they were heated above 80 °C. Moreover, 
the molecular weights of active fractions of precipitated 
proteins from both N2-4 and N3-8 were suspected to be 
less than 11  kDa. This information could indicate their 
metabolites to contain small peptides similar to bacteri-
ocin antibiotics. Other compounds those were still active 
after proteolytic enzyme digestion could be the non-pep-
tides group such as lipopeptides or polyketides. These 
Fig. 3 Time-kill assay of precipitated proteins from B. amyloliquefaciens against B. pseudomallei. a Concentrations of precipitated proteins with 
the MBCs against B. pseudomallei from B. amyloliquefaciens N2-4 were used to lyse B. pseudomallei. The X axis indicates time in hours after various 
concentrations of the proteins as indicated (mg/mL) were added into B. pseudomallei cultures and the Y axis indicates the CFU/ml of B. pseudomallei 
after treatment. b Proteins from B. amyloliquefaciens N3-8 were tested in the same manner
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antimicrobial substances were reported to resist a wide 
range of temperatures up to 100  °C (Pathak and Keha-
ria 2014) and were also resistant to proteolytic enzyme 
digestion (Zhao et al. 2013).
The active compounds produced from both B. 
amyloliquefaciens N2-4 and N3-8 isolates were able 
to inhibit several strains of B. pseudomallei from both 
clinical and environmental sources including antibiotic 
resistant isolates. Moreover, they could inhibit other 
Gram-positive and Gram-negative bacteria such as 
E. coli, S. aureus, E. faecium and C. difficile as shown 
by the cross-streak method. Surprisingly, these anti-
microbial compounds did not inhibit B. thailanden-
sis the non-pathogenic bacteria that is closely related 
to B. pseudomallei. The difference in lipopolysaccha-
ride (LPS) structure between the B. pseudomallei and 
B. thailandensis have been reported (Knirel et al. 1992; 
Perry et  al. 1995) together with the difference in their 
genomes (Brett et  al. 1998) may contribute to the dif-
ference in their susceptibility to the antimicrobial com-
pounds. Most of B. pseudomallei in Thailand have the 
Fig. 4 Antimicrobial activity of precipitated proteins from B. amyloliquefaciens N2-4 and N3-8 isolates in native-PAGE against B. pseudomallei. a Clear 
inhibition zones of precipitated proteins from a strip of native-PAGE that was placed on the B. pseudomallei lawn. b Precipitated proteins from N2-4 
and 3-8 were separated by native-PAGE and visualized by silver staining. M represents the size marker
Fig. 5 Bio-control by co-culture B. pseudomallei with B. amylolique-
faciens. The colony count of B. pseudomallei was plotted on the Y axis 
and time in hours on the X axis after co-culture with B. amylolique-
faciens isolates N2-4 (red line) and N3-8 (blue line) and the green line 
indicates the growth of un-treated B. pseudomallei as a control
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LPS genotype A (Tuanyok et  al. 2012) and K96243 and 
1026b strains with genotype A were susceptible to N2-4 
and N3-8 metabolites, however, the SRM117 LPS O-side 
chain mutant was susceptible to N3-8 but not N2-4. 
Moreover, M6 and M10, which are biofilm mutants, 
were more susceptible to N3-8 than N2-4. The non-
peptides compounds that are present in N3-8 but much 
less or none in the N2-4 as observed by heat and proteo-
lytic stability test may be responsible for the differences 
when the culture supernatants were used to test for the 
spectrum of inhibition. Therefore, the precipitated pro-
teins from N2-4 and N3-8 were prepared and tested with 
some pathogenic bacteria by agar well diffusion. Besides 
S. pyogenes and M. catarrhalis that showed equal inhibi-
tion, most of the test organisms were better inhibited by 
N3-8 than N2-4. Moreover, V. parahaemolyticus showed 
resistance to N2-4 but not N3-8. In general, most pep-
tide antibiotics can inhibit bacteria in a narrow range or 
only closely related bacteria. Nevertheless, a bacteriocin-
like substance of Bacillus spp. was reported to inhibit a 
broad-range of bacteria (Guo et al. 2012; Lee et al. 2001; 
Motta et al. 2007; Xie et al. 2009) that included B. amy-
oliquefaciens LBM5006 that inhibited L. monocytogenes, 
B. cereus, Serratia marcescens, E.  coli, P. aeruginosa, P. 
fluorescens, S. cholerasuis, and S. gallinarum (Benitez 
et al. 2011). Similarly in this present study, the precipi-
tated proteins from B. amyloliquefaciens N2-4 and N3-8 
showed a broad range of inhibition. The metabolites of 
these two isolates should contain different compounds 
and the non-peptide metabolites in N3-8 may have a 
synergistic effect against these pathogens.
Several strains of B. amyloliquefaciens were studied to 
be used as bio-control agents such as the FZB42 strain 
that was dual-cultured with E. amylovora, both in  vitro 
and in vivo, and showed inhibition activity in the growth 
of the pathogens (Chen et al. 2009). When B. amylolique-
faciens N2-4 and N3-8 were co-cultured with B. 
pseudomallei, they could decrease the growth of B. pseu-
domallei by 5 log10 in 72 h. The time of B. pseudomallei 
decrease was correlated with the time when the second-
ary metabolites from N2-4 and N3-8 were produced. 
Even though metabolites from N2-4 and N3-8 showed 
a broad spectrum of inhibition against both Gram-pos-
itive and Gram-negative pathogens, they did not affect 
B. thailandensis, a non-pathogenic bacterium from soil. 
Purification and characterization of both peptides and 
non-peptides from both isolates and the tests for their 
spectrum of inhibition may lead to a better knowledge to 
design a way for controlling B. pseudomallei in soil, and 
may also be extended to discover some important com-
pounds to attack several problematic pathogens in the 
near future.
In conclusion, B. amyloliquefaciens N2-4 and N3-8 iso-
lates obtained from soil can produce both peptides and 
non-peptide metabolites that can inhibit B. pseudomal-
lei and a broad range of other pathogenic bacteria. After 
purification and characterization, the bacteria themselves 
or their metabolites could be used as bio-controls to 
reduce the pathogenic bacteria in soil of endemic B. pseu-
domallei areas. Moreover, if the compounds are novel 
and safe, they may be good candidates for the develop-
ment of new drugs.
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